Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer

被引:11
作者
Nam, Su Youn [1 ]
Jeon, Seong Woo [1 ]
Lee, Hyun Seok [1 ]
Kwon, Yong Hwan [1 ]
Park, Haeyoon [1 ]
Choi, Jin Woo [1 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Med Ctr, Daegu, South Korea
关键词
Eradication; Helicobacter pylori; Long term follow-up; Pepsinogen; ACID-SUPPRESSIVE THERAPY; SERUM PEPSINOGEN; CELLULAR-LOCALIZATION; INFECTION; DIAGNOSIS; ATROPHY; RISK; IMMUNOFLUORESCENCE; CARCINOMA; HISTOLOGY;
D O I
10.1016/j.dld.2016.12.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although the pepsinogen I/II (PGI/II) ratio after Helicobacter pylori eradication is recovered at short-term follow-up, long-term follow-up studies of PGI/II are rare. Methods: A total of 773 patients with gastric cancer who underwent endoscopic resection and pepsinogen and H. pylori tests were enrolled. H. pylori was eradicated in these patients. Endoscopic and pepsinogen tests were performed every year. A low PGI/II ratio was defined as <= 3. Results: The PGI/II ratio was higher in non-infected patients (n = 275, 4.99) than infected patients (n = 498, 3.53). After H. pylori eradication, the PGI/II ratio increased to 5.81 and 5.63 after 1 and 2 years (each p < 0.05). The PGI/II ratio in the non-eradication group decreased to 3.94 and 2.75 after 1 and 2 years. The PGI/II ratio in the H. pylori eradication group became similar to that of the H. pylori-negative group at 3 (4.48 vs. 4.34), 4 (4.88 vs. 4.34), and 5 years (4.89 vs. 4.23). The adjusted odds ratios for a lower PG I/II ratio in the non-eradication group compared to the eradication group were 4.78 (95% CI 2.15-10.67) after 1 year and 8.13 (95% CI 2.56-25.83) after 2 years. Conclusions: After H. pylori eradication, the PGI/II ratio increased and was similar to that of H. pylori-negative controls for up to 5 years of follow-up. (C) 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:500 / 506
页数:7
相关论文
共 33 条
[1]   Endoscopic Gastric Cancer Screening and Surveillance in High-Risk Groups [J].
Choi, Il Ju .
CLINICAL ENDOSCOPY, 2014, 47 (06) :497-503
[2]   Natural history of Helicobacter pylori infection [J].
Correa, P. ;
Piazuelo, M. B. .
DIGESTIVE AND LIVER DISEASE, 2008, 40 (07) :490-496
[3]   Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma [J].
Dinis-Ribeiro, M ;
da Costa-Pereira, A ;
Lopes, C ;
Barbosa, J ;
Guilherme, M ;
Moreira-Dias, L ;
Lomba-Viana, H ;
Silva, R ;
Abreu, N ;
Lomba-Viana, R .
NEOPLASIA, 2004, 6 (05) :449-456
[4]  
Do Mi Young, 2009, Korean J Gastroenterol, V53, P76
[5]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[6]  
Furuta T, 1997, AM J GASTROENTEROL, V92, P84
[7]   Noninvasive versus histologic detection of gastric atrophy in a hispanic population in North America [J].
Graham, DY ;
Nurgalieva, ZZ ;
El-Zimaity, HMT ;
Opekun, AR ;
Campos, A ;
Guerrero, L ;
Chavez, A ;
Cardenas, V .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (03) :306-314
[8]   Serum pepsinogen II: A neglected but useful biomarker to differentiate between diseased and normal stomachs [J].
He, Cai-yun ;
Sun, Li-ping ;
Gong, Yue-hua ;
Xu, Qian ;
Dong, Nan-nan ;
Yuan, Yuan .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (06) :1039-1046
[9]   Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication [J].
Iijima, Katsunori ;
Koike, Tomoyuki ;
Abe, Yasuhiko ;
Ara, Nobuyuki ;
Uno, Kaname ;
Imatani, Akira ;
Ohara, Shuichi ;
Shimosegawa, Tooru .
JOURNAL OF GASTROENTEROLOGY, 2009, 44 (08) :819-825
[10]   Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach [J].
Iijima, Katsunori ;
Abe, Yasuhiko ;
Kikuchi, Ryosuke ;
Koike, Tomoyuki ;
Ohara, Shuichi ;
Sipponen, Pentti ;
Shimosegawa, Tooru .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (07) :853-859